Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
2023;31(XX):XXXX
Therapeutic Advances in Reproductive Health , 15 , 1-22
Li BU, Murray RD, Heitlinger LA, et al
But right now, state employees and people on MassHealth are petrified. All carriers with the Massachusetts Health Connector decided to stop covering GLP-drugs for 2026 strictly for weight loss, and additional GLP-1 cost pressure could come from MassHealth
The result at week 88: Continued tirzepatide: :Lost an additional 5.5% of body weight (total loss from baseline: ~25%) Switched to placebo: Regained 14.0% of body weight (net loss from baseline: ~9%) A 19-point swing between continued and discontinued groups
US$ 25.68
US$ 21.89
US$ 26.54
US$ 25.57
US$ 25.35
